These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6242013)

  • 1. Reversal of impaired renal function in rats with streptozotocin-induced diabetes by transplantation of isolated pancreatic islets: failure in preventing the progress of glomerulosclerosis.
    Yamamoto T; Kawamura J; Yoshida O; Tobe T
    Nihon Geka Hokan; 1984 Nov; 53(6):721-35. PubMed ID: 6242013
    [No Abstract]   [Full Text] [Related]  

  • 2. [Regression of diabetic glomerular changes following islet transplantation. A study of rats with streptozotocin diabetes].
    Kösters W
    Fortschr Med; 1979 May; 97(17):825-9. PubMed ID: 155638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention by L-dopa of early renal consequences of diabetes induced by streptozocin in rats].
    Vailly B; Barthelmebs M; Velly J; Grima M; Imbs JL
    Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1259-62. PubMed ID: 2148079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiating between effects of streptozotocin per se and subsequent hyperglycemia on renal function and metabolism in the streptozotocin-diabetic rat model.
    Palm F; Ortsäter H; Hansell P; Liss P; Carlsson PO
    Diabetes Metab Res Rev; 2004; 20(6):452-9. PubMed ID: 15386825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diabetes. Reversion of diabetic kidney lesions by islands of Langerhans transplantation in rats. Quantitative morphology].
    Bretzel RG; Federlin K
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1373-7. PubMed ID: 417493
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathogenesis of cardiovascular disorders in streptozotocin-induced diabetes in rat. I. Cardiovascular, renal and morphologic changes in different stages of diabetes.
    Somova L; Dashev G; Doncheva M; Vassileva M
    Acta Physiol Pharmacol Bulg; 1988; 14(3):46-56. PubMed ID: 3066111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic nephropathy. Pathogenesis and prevention.
    Westberg NG
    Acta Endocrinol Suppl (Copenh); 1980; 238():85-101. PubMed ID: 6933819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of islet transplantation on renal function and morphology of short- and long-term diabetic rats.
    Weber CJ; Silva FG; Hardy MA; Pirani CL; Reemtsma K
    Transplant Proc; 1979 Mar; 11(1):549-56. PubMed ID: 109966
    [No Abstract]   [Full Text] [Related]  

  • 9. Protective effect of nicotinamide against nephropathy in diabetic rats.
    Wahlberg G; Carlson LA; Wasserman J; Ljungqvist A
    Diabetes Res; 1985 Nov; 2(6):307-12. PubMed ID: 2934204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of diabetes by isogeneic transplantation of cultured pancreatic islets.
    Ziegler B; Lorenz D; Lippert H; Butter R; Ziegler M; Hahn HJ
    Endokrinologie; 1981 Jul; 77(3):346-52. PubMed ID: 6268393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of aspirin on experimental diabetic nephropathy.
    Moel DI; Safirstein RL; McEvoy RC; Hsueh W
    J Lab Clin Med; 1987 Sep; 110(3):300-7. PubMed ID: 3475395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role for local prostaglandin and thromboxane production in the regulation of glomerular filtration rate in the rat with streptozocin-induced diabetes.
    Craven PA; DeRubertis FR
    J Lab Clin Med; 1989 Jun; 113(6):674-81. PubMed ID: 2525167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Islet transplantation in experimental diabetes of the rat. V. Regression of glomerular lesions in diabetic rats after intraportal transplantation of isogeneic islets. Preliminary results.
    Federlin K; Bretzel RG; Schmidtchen U
    Horm Metab Res; 1976 Sep; 8(5):404-6. PubMed ID: 135720
    [No Abstract]   [Full Text] [Related]  

  • 14. Repeated isologous transplantation of islets of Langerhans in the diabetic rat.
    Henriksson C
    Acta Chir Scand; 1978; 144(3):137-40. PubMed ID: 211767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphometric detection of incipient glomerular lesions in diabetic nephropathy in rats. Protective effects of ACE inhibition.
    Sassy-Prigent C; Heudes D; Jouquey S; Auberval D; Belair MF; Michel O; Hamon G; Bariety J; Bruneval P
    Lab Invest; 1995 Jul; 73(1):64-71. PubMed ID: 7603042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glomerular hemodynamic and structural correlations in long-term experimental diabetic rats.
    Michels LD; O'Donnell MP; Keane WF
    J Lab Clin Med; 1984 Jun; 103(6):840-7. PubMed ID: 6726055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration of glomerular hyperfiltration in acute experimental diabetes mellitus by dietary myo-inositol supplementation and aldose reductase inhibition.
    Goldfarb S; Simmons DA; Kern EF
    Trans Assoc Am Physicians; 1986; 99():67-72. PubMed ID: 3111062
    [No Abstract]   [Full Text] [Related]  

  • 18. Tubuloglomerular feedback in renal hypertrophy.
    Pollock CA; Lawrence JR; Field MJ
    Kidney Int Suppl; 1991 Jun; 32():S106-9. PubMed ID: 1881031
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of KATP channel blocker U37883A on renal function in experimental diabetes mellitus in rats.
    Vallon V; Albinus M; Blach D
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1215-21. PubMed ID: 9732381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
    Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.